Pfiz­er and BioN­Tech file BLA for Omi­cron-tar­get­ing Covid-19 vac­cine

Pfiz­er and BioN­Tech are seek­ing full ap­proval for their Omi­cron-tar­get­ed bi­va­lent Covid shot, and they’re fol­low­ing an FDA ad­vi­so­ry com­mit­tee’s ad­vice on “har­mo­niz­ing” vac­cine com­po­si­tions …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER